Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Interleukin-36 receptor antagonist protein (IL-36Ra) (FIL1 delta) (IL-1-related protein 3) (IL-1RP3) (Interleukin-1 HY1) (IL-1HY1) (Interleukin-1 delta) (IL-1 delta) (Interleukin-1 family member 5) (IL-1F5) (Interleukin-1 receptor antagonist homolog 1) (IL-1ra homolog 1) (Interleukin-1-like protein 1) (IL-1L1)

 I36RA_HUMAN             Reviewed;         155 AA.
Q9UBH0; A8K2I4; Q56AT9; Q7RTZ6;
08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
01-MAY-2000, sequence version 1.
30-AUG-2017, entry version 149.
RecName: Full=Interleukin-36 receptor antagonist protein;
Short=IL-36Ra {ECO:0000303|PubMed:21965679};
AltName: Full=FIL1 delta;
AltName: Full=IL-1-related protein 3;
Short=IL-1RP3;
AltName: Full=Interleukin-1 HY1;
Short=IL-1HY1;
AltName: Full=Interleukin-1 delta;
Short=IL-1 delta;
AltName: Full=Interleukin-1 family member 5;
Short=IL-1F5;
AltName: Full=Interleukin-1 receptor antagonist homolog 1;
Short=IL-1ra homolog 1;
AltName: Full=Interleukin-1-like protein 1;
Short=IL-1L1;
Name=IL36RN; Synonyms=FIL1D, IL1F5, IL1HY1, IL1L1, IL1RP3;
ORFNames=UNQ1896/PRO4342;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Placenta;
PubMed=10625660; DOI=10.1074/jbc.275.2.1169;
Smith D.E., Renshaw B.R., Ketchem R.R., Kubin M., Garka K.E.,
Sims J.E.;
"Four new members expand the IL-1 superfamily.";
J. Biol. Chem. 275:1169-1175(2000).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Fetal skin;
PubMed=10512743; DOI=10.1006/bbrc.1999.1440;
Mulero J.J., Pace A.M., Nelken S.T., Loeb D.B., Correa T.R.,
Drmanac R., Ford J.E.;
"IL1HY1: a novel interleukin-1 receptor antagonist gene.";
Biochem. Biophys. Res. Commun. 263:702-706(1999).
[3]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Placenta;
PubMed=11093146;
DOI=10.1002/1521-4141(200011)30:11<3299::AID-IMMU3299>3.0.CO;2-S;
Barton J.L., Herbst R., Bosisio D., Higgins L., Nicklin M.J.H.;
"A tissue specific IL-1 receptor antagonist homolog from the IL-1
cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities.";
Eur. J. Immunol. 30:3299-3308(2000).
[4]
NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
PubMed=11466363; DOI=10.4049/jimmunol.167.3.1440;
Debets R., Timans J.C., Homey B., Zurawski S., Sana T.R., Lo S.,
Wagner J., Edwards G., Clifford T., Menon S., Bazan J.F.,
Kastelein R.A.;
"Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function
as an antagonist and agonist of NF-kappa B activation through the
orphan IL-1 receptor-related protein 2.";
J. Immunol. 167:1440-1446(2001).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=10860666; DOI=10.1006/geno.2000.6184;
Busfield S.J., Comrack C.A., Yu G., Chickering T.W., Smutko J.S.,
Zhou H., Leiby K.R., Holmgren L.M., Gearing D.P., Pan Y.;
"Identification and gene organization of three novel members of the
IL-1 family on human chromosome 2.";
Genomics 66:213-216(2000).
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=11991722; DOI=10.1006/geno.2002.6751;
Nicklin M.J.H., Barton J.L., Nguyen M., Fitzgerald M.G., Duff W.G.,
Kornman K.;
"A sequence-based map of the nine genes of the human interleukin-1
cluster.";
Genomics 79:718-725(2002).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
PubMed=12975309; DOI=10.1101/gr.1293003;
Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
Wood W.I., Godowski P.J., Gray A.M.;
"The secreted protein discovery initiative (SPDI), a large-scale
effort to identify novel human secreted and transmembrane proteins: a
bioinformatics assessment.";
Genome Res. 13:2265-2270(2003).
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Cervix;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[9]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-47.
SeattleSNPs variation discovery resource;
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
[10]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15815621; DOI=10.1038/nature03466;
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2
and 4.";
Nature 434:724-731(2005).
[11]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[12]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Placenta;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[13]
FUNCTION, AND CLEAVAGE OF INITIATOR METHIONINE.
PubMed=21965679; DOI=10.1074/jbc.M111.267922;
Towne J.E., Renshaw B.R., Douangpanya J., Lipsky B.P., Shen M.,
Gabel C.A., Sims J.E.;
"Interleukin-36 (IL-36) ligands require processing for full agonist
(IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra)
activity.";
J. Biol. Chem. 286:42594-42602(2011).
[14]
FUNCTION, AND INDUCTION.
PubMed=23147407; DOI=10.1002/eji.201242711;
Gresnigt M.S., Roesler B., Jacobs C.W., Becker K.L., Joosten L.A.,
van der Meer J.W., Netea M.G., Dinarello C.A., van de Veerdonk F.L.;
"The IL-36 receptor pathway regulates Aspergillus fumigatus-induced
Th1 and Th17 responses.";
Eur. J. Immunol. 43:416-426(2013).
[15]
VARIANTS PSORS14 TRP-48 AND LEU-113.
PubMed=21839423; DOI=10.1016/j.ajhg.2011.07.022;
Onoufriadis A., Simpson M.A., Pink A.E., Di Meglio P., Smith C.H.,
Pullabhatla V., Knight J., Spain S.L., Nestle F.O., Burden A.D.,
Capon F., Trembath R.C., Barker J.N.;
"Mutations in IL36RN/IL1F5 are associated with the severe episodic
inflammatory skin disease known as generalized pustular psoriasis.";
Am. J. Hum. Genet. 89:432-437(2011).
[16]
VARIANT PSORS14 PRO-27, AND CHARACTERIZATION OF VARIANT PSORS14
PRO-27.
PubMed=21848462; DOI=10.1056/NEJMoa1013068;
Marrakchi S., Guigue P., Renshaw B.R., Puel A., Pei X.Y., Fraitag S.,
Zribi J., Bal E., Cluzeau C., Chrabieh M., Towne J.E., Douangpanya J.,
Pons C., Mansour S., Serre V., Makni H., Mahfoudh N., Fakhfakh F.,
Bodemer C., Feingold J., Hadj-Rabia S., Favre M., Genin E.,
Sahbatou M., Munnich A., Casanova J.L., Sims J.E., Turki H.,
Bachelez H., Smahi A.;
"Interleukin-36-receptor antagonist deficiency and generalized
pustular psoriasis.";
N. Engl. J. Med. 365:620-628(2011).
[17]
VARIANT PSORS14 ARG-123, AND CHARACTERIZATION OF VARIANT PSORS14
ARG-123.
PubMed=22903787; DOI=10.1002/humu.22203;
Farooq M., Nakai H., Fujimoto A., Fujikawa H., Matsuyama A.,
Kariya N., Aizawa A., Fujiwara H., Ito M., Shimomura Y.;
"Mutation analysis of the IL36RN gene in 14 Japanese patients with
generalized pustular psoriasis.";
Hum. Mutat. 34:176-183(2013).
-!- FUNCTION: Inhibits the activity of interleukin-36 (IL36A,IL36B and
IL36G) by binding to receptor IL1RL2 and preventing its
association with the coreceptor IL1RAP for signaling. Part of the
IL-36 signaling system that is thought to be present in epithelial
barriers and to take part in local inflammatory response; similar
to the IL-1 system with which it shares the coreceptor. Proposed
to play a role in skin inflammation. May be involved in the innate
immune response to fungal pathogens, such as Aspergillus
fumigatus. May activate an anti-inflammatory signaling pathway by
recruiting SIGIRR. {ECO:0000269|PubMed:11466363,
ECO:0000269|PubMed:21965679, ECO:0000269|PubMed:23147407}.
-!- INTERACTION:
Q04864:REL; NbExp=3; IntAct=EBI-465156, EBI-307352;
Q9BWW4:SSBP3; NbExp=5; IntAct=EBI-465156, EBI-2902395;
Q9BWG4:SSBP4; NbExp=3; IntAct=EBI-465156, EBI-744719;
-!- SUBCELLULAR LOCATION: Secreted.
-!- TISSUE SPECIFICITY: Predominantly expressed in skin keratinocytes
but not in fibroblasts, endothelial cells or melanocytes. Detected
also in the spleen, brain leukocyte and macrophage cell types.
Increased in lesional psoriasis skin.
{ECO:0000269|PubMed:11466363}.
-!- INDUCTION: By phorbol ester (PMA) and bacterial
lipopolysaccharides (LPS) treatment in macrophage cell line. By
Aspergillus fumigatus conidia in peripheral blood mnonocytes.
{ECO:0000269|PubMed:23147407}.
-!- DISEASE: Psoriasis 14, pustular (PSORS14) [MIM:614204]: A life-
threatening disease defined by repeated flares of sudden onset
consisting of diffuse erythematous skin eruption characterized by
rapid coverage with pustules, high-grade fever, asthenia, marked
leukocytosis, and elevated serum levels of C-reactive protein.
{ECO:0000269|PubMed:21839423, ECO:0000269|PubMed:21848462,
ECO:0000269|PubMed:22903787}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the IL-1 family. {ECO:0000305}.
-!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-1 entry;
URL="https://en.wikipedia.org/wiki/Interleukin_1";
-!- WEB RESOURCE: Name=SeattleSNPs;
URL="http://pga.gs.washington.edu/data/il1f5/";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF201830; AAF25210.1; -; mRNA.
EMBL; AF186094; AAF02757.1; -; mRNA.
EMBL; AJ242737; CAB59822.1; -; mRNA.
EMBL; AJ242738; CAB59823.1; -; mRNA.
EMBL; AJ271338; CAB67704.1; -; Genomic_DNA.
EMBL; AF216693; AAF76981.1; -; Genomic_DNA.
EMBL; AF230377; AAF91274.1; -; mRNA.
EMBL; BN000002; CAD29877.1; -; Genomic_DNA.
EMBL; AY359117; AAQ89475.1; -; mRNA.
EMBL; AK290249; BAF82938.1; -; mRNA.
EMBL; AY972853; AAX59031.1; -; Genomic_DNA.
EMBL; AC016724; AAY14990.1; -; Genomic_DNA.
EMBL; CH471217; EAW73617.1; -; Genomic_DNA.
EMBL; BC024747; AAH24747.1; -; mRNA.
CCDS; CCDS2111.1; -.
PIR; JC7104; JC7104.
RefSeq; NP_036407.1; NM_012275.2.
RefSeq; NP_775262.1; NM_173170.1.
UniGene; Hs.516301; -.
PDB; 4P0J; X-ray; 2.30 A; A/B=2-135, A/B=147-155.
PDB; 4P0K; X-ray; 1.70 A; A=2-49, A=55-135, A=147-155.
PDB; 4P0L; X-ray; 1.55 A; A=2-49, A=55-135, A=147-155.
PDBsum; 4P0J; -.
PDBsum; 4P0K; -.
PDBsum; 4P0L; -.
ProteinModelPortal; Q9UBH0; -.
SMR; Q9UBH0; -.
BioGrid; 117728; 16.
IntAct; Q9UBH0; 14.
MINT; MINT-1194342; -.
STRING; 9606.ENSP00000259212; -.
iPTMnet; Q9UBH0; -.
PhosphoSitePlus; Q9UBH0; -.
BioMuta; IL36RN; -.
DMDM; 25008600; -.
EPD; Q9UBH0; -.
PaxDb; Q9UBH0; -.
PeptideAtlas; Q9UBH0; -.
PRIDE; Q9UBH0; -.
DNASU; 26525; -.
Ensembl; ENST00000346807; ENSP00000259212; ENSG00000136695.
Ensembl; ENST00000393200; ENSP00000376896; ENSG00000136695.
GeneID; 26525; -.
KEGG; hsa:26525; -.
UCSC; uc002tis.4; human.
CTD; 26525; -.
DisGeNET; 26525; -.
GeneCards; IL36RN; -.
HGNC; HGNC:15561; IL36RN.
HPA; HPA034542; -.
MalaCards; IL36RN; -.
MIM; 605507; gene.
MIM; 614204; phenotype.
neXtProt; NX_Q9UBH0; -.
OpenTargets; ENSG00000136695; -.
Orphanet; 163931; Acrodermatitis continua suppurativa of Hallopeau.
Orphanet; 404546; DITRA.
Orphanet; 247353; Generalized pustular psoriasis.
Orphanet; 163927; Pustulosis palmaris et plantaris.
PharmGKB; PA38388; -.
eggNOG; ENOG410IZIW; Eukaryota.
eggNOG; ENOG41116AA; LUCA.
GeneTree; ENSGT00530000062899; -.
HOVERGEN; HBG052099; -.
InParanoid; Q9UBH0; -.
KO; K05483; -.
OMA; ALCFRMK; -.
OrthoDB; EOG091G0PWA; -.
PhylomeDB; Q9UBH0; -.
TreeFam; TF300203; -.
Reactome; R-HSA-449836; Other interleukin signaling.
GeneWiki; IL1F5; -.
GenomeRNAi; 26525; -.
PRO; PR:Q9UBH0; -.
Proteomes; UP000005640; Chromosome 2.
Bgee; ENSG00000136695; -.
CleanEx; HS_IL1F5; -.
ExpressionAtlas; Q9UBH0; baseline and differential.
Genevisible; Q9UBH0; HS.
GO; GO:0005576; C:extracellular region; TAS:Reactome.
GO; GO:0005615; C:extracellular space; IBA:GO_Central.
GO; GO:0005125; F:cytokine activity; IBA:GO_Central.
GO; GO:0005152; F:interleukin-1 receptor antagonist activity; TAS:ProtInc.
GO; GO:0005149; F:interleukin-1 receptor binding; IBA:GO_Central.
GO; GO:0019732; P:antifungal humoral response; IMP:UniProtKB.
GO; GO:0006954; P:inflammatory response; IEA:InterPro.
GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
GO; GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IMP:UniProtKB.
GO; GO:1902714; P:negative regulation of interferon-gamma secretion; IMP:UniProtKB.
GO; GO:0032700; P:negative regulation of interleukin-17 production; IMP:UniProtKB.
GO; GO:0032715; P:negative regulation of interleukin-6 production; IEA:Ensembl.
InterPro; IPR020877; IL-1_CS.
InterPro; IPR000975; IL-1_fam.
InterPro; IPR003297; IL-1RA/IL-36.
InterPro; IPR027171; IL-36RA.
InterPro; IPR008996; IL1/FGF.
PANTHER; PTHR10078:SF58; PTHR10078:SF58; 1.
Pfam; PF00340; IL1; 1.
PRINTS; PR00264; INTERLEUKIN1.
PRINTS; PR01360; INTRLEUKIN1X.
SUPFAM; SSF50353; SSF50353; 1.
PROSITE; PS00253; INTERLEUKIN_1; 1.
1: Evidence at protein level;
3D-structure; Complete proteome; Cytokine; Disease mutation;
Disulfide bond; Immunity; Innate immunity; Polymorphism;
Reference proteome; Secreted.
INIT_MET 1 1 Removed. {ECO:0000269|PubMed:21965679}.
CHAIN 2 155 Interleukin-36 receptor antagonist
protein.
/FTId=PRO_0000153642.
DISULFID 8 154 {ECO:0000250}.
VARIANT 27 27 L -> P (in PSORS14; expression of the
protein is severely impaired compared to
wild-type; the mutant protein is
substantially less able to inhibit IL1RL2
signaling than wild-type;
dbSNP:rs387906914).
{ECO:0000269|PubMed:21848462}.
/FTId=VAR_066646.
VARIANT 47 47 N -> S (in dbSNP:rs28938777).
{ECO:0000269|Ref.9}.
/FTId=VAR_023239.
VARIANT 48 48 R -> W (in PSORS14; dbSNP:rs151325121).
{ECO:0000269|PubMed:21839423}.
/FTId=VAR_066647.
VARIANT 113 113 S -> L (in PSORS14; dbSNP:rs144478519).
{ECO:0000269|PubMed:21839423}.
/FTId=VAR_066648.
VARIANT 123 123 T -> R (in PSORS14; shows impaired
expression of the mutant protein which
fails to antagonize the IL-36 signaling
pathway; dbSNP:rs397514629).
{ECO:0000269|PubMed:22903787}.
/FTId=VAR_068972.
STRAND 9 13 {ECO:0000244|PDB:4P0L}.
STRAND 18 22 {ECO:0000244|PDB:4P0L}.
STRAND 25 29 {ECO:0000244|PDB:4P0L}.
STRAND 42 46 {ECO:0000244|PDB:4P0L}.
HELIX 50 52 {ECO:0000244|PDB:4P0L}.
STRAND 56 61 {ECO:0000244|PDB:4P0J}.
TURN 62 65 {ECO:0000244|PDB:4P0J}.
STRAND 66 69 {ECO:0000244|PDB:4P0J}.
STRAND 72 75 {ECO:0000244|PDB:4P0J}.
STRAND 79 82 {ECO:0000244|PDB:4P0J}.
HELIX 85 89 {ECO:0000244|PDB:4P0J}.
HELIX 96 98 {ECO:0000244|PDB:4P0J}.
STRAND 99 105 {ECO:0000244|PDB:4P0J}.
STRAND 108 116 {ECO:0000244|PDB:4P0J}.
STRAND 120 123 {ECO:0000244|PDB:4P0J}.
STRAND 132 135 {ECO:0000244|PDB:4P0L}.
STRAND 143 146 {ECO:0000244|PDB:4P0L}.
STRAND 149 153 {ECO:0000244|PDB:4P0L}.
SEQUENCE 155 AA; 16962 MW; B96DB5EFA2612E25 CRC64;
MVLSGALCFR MKDSALKVLY LHNNQLLAGG LHAGKVIKGE EISVVPNRWL DASLSPVILG
VQGGSQCLSC GVGQEPTLTL EPVNIMELYL GAKESKSFTF YRRDMGLTSS FESAAYPGWF
LCTVPEADQP VRLTQLPENG GWNAPITDFY FQQCD


Related products :

Catalog number Product name Quantity
orb82722 Human IL1 RN protein Recombinant Human Interleukin-1 Receptor Antagonist is a member of the Interleukin-1cytokine family. IL1RN inhibits the activities of Interleukin-1 alpha (IL1A) and Interleukin-1 1 mg
E2205h Homo sapiens,Human,IL-1 epsilon,IL1E,IL1F9,IL-1F9,IL1H1,IL-1H1,IL-1-related protein 2,IL1RP2,IL-1RP2,IL36G,Interleukin-1 epsilon,Interleukin-1 family member 9,Interleukin-1 homolog 1,Interleukin-36 ga
E2205h ELISA Homo sapiens,Human,IL-1 epsilon,IL1E,IL1F9,IL-1F9,IL1H1,IL-1H1,IL-1-related protein 2,IL1RP2,IL-1RP2,IL36G,Interleukin-1 epsilon,Interleukin-1 family member 9,Interleukin-1 homolog 1,Interleukin 96T
U2205h CLIA Homo sapiens,Human,IL-1 epsilon,IL1E,IL1F9,IL-1F9,IL1H1,IL-1H1,IL-1-related protein 2,IL1RP2,IL-1RP2,IL36G,Interleukin-1 epsilon,Interleukin-1 family member 9,Interleukin-1 homolog 1,Interleukin- 96T
U2205h CLIA kit Homo sapiens,Human,IL-1 epsilon,IL1E,IL1F9,IL-1F9,IL1H1,IL-1H1,IL-1-related protein 2,IL1RP2,IL-1RP2,IL36G,Interleukin-1 epsilon,Interleukin-1 family member 9,Interleukin-1 homolog 1,Interle 96T
E2205h ELISA kit Homo sapiens,Human,IL-1 epsilon,IL1E,IL1F9,IL-1F9,IL1H1,IL-1H1,IL-1-related protein 2,IL1RP2,IL-1RP2,IL36G,Interleukin-1 epsilon,Interleukin-1 family member 9,Interleukin-1 homolog 1,Interl 96T
26-207 IL1RAPL2 is a member of the interleukin 1 receptor family. This protein is similar to the interleukin 1 accessory proteins, and is most closely related to interleukin 1 receptor accessory protein-like 0.05 mg
E0066h ELISA CD121 antigen-like family member B,CDw121b,Homo sapiens,Human,IL1R2,IL-1R-2,IL1RB,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor typ 96T
orb82731 Human IL4 protein Interleukin-4 (IL4) is a pleiotropic cytokine produced by activated T cells. IL4 is a ligandfor interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which maycontri 1 mg
E0066h ELISA kit CD121 antigen-like family member B,CDw121b,Homo sapiens,Human,IL1R2,IL-1R-2,IL1RB,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 recepto 96T
E0065h ELISA kit CD121 antigen-like family member A,Homo sapiens,Human,IL1R,IL1R1,IL-1R-1,IL1RA,IL-1R-alpha,IL1RT1,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 r 96T
E0065h ELISA CD121 antigen-like family member A,Homo sapiens,Human,IL1R,IL1R1,IL-1R-1,IL1RA,IL-1R-alpha,IL1RT1,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 recept 96T
U0065h CLIA CD121 antigen-like family member A,Homo sapiens,Human,IL1R,IL1R1,IL-1R-1,IL1RA,IL-1R-alpha,IL1RT1,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 recepto 96T
10-783-79055 RECOMBINANT HUMAN INTERLEUKIN-1RA - INTERLEUKIN-1 RECEPTOR ANTAGONIST; 0.02 mg
U0066h CLIA CD121 antigen-like family member B,CDw121b,Homo sapiens,Human,IL1R2,IL-1R-2,IL1RB,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type 96T
U0065m CLIA CD121 antigen-like family member A,Il1r1,Il-1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,Mouse,Mus muscu 96T
E0066r ELISA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Rat,Rattus norv 96T
E0065r ELISA CD121 antigen-like family member A,Il1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,p80,Rat,Rattus norveg 96T
E0065m ELISA CD121 antigen-like family member A,Il1r1,Il-1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,Mouse,Mus musc 96T
U0065r CLIA CD121 antigen-like family member A,Il1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,p80,Rat,Rattus norvegi 96T
E0066m ELISA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Mouse,Mus muscu 96T
U0066m CLIA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Mouse,Mus muscul 96T
U0066r CLIA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Rat,Rattus norve 96T
E0065m ELISA kit CD121 antigen-like family member A,Il1r1,Il-1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,Mouse,Mus 96T
E0066r ELISA kit CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Rat,Rattus 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur